ライフサイエンスコーパス: antihypertensives

1 es in prescription rates of both statins and antihypertensives.

2 midodrine, 50% were concomitantly prescribed antihypertensives.

3 all survival compared with patients on other antihypertensives.

4 p were able to achieve SPRINT levels without antihypertensives.

5 etics are among the most commonly prescribed antihypertensives.

6 nexpander states saw declines in statins and antihypertensives.

7 a lower cholesterol level and less need for antihypertensives.

8 on-years among those who were not prescribed antihypertensives.

9 ternal trials of dual and triple combination antihypertensives.

10 ified monitoring in the ICU with intravenous antihypertensives.

11 rch avenue, including in respect of systemic antihypertensives.

12 Mean age was 67.7 years; 80.9% used antihypertensives.

13 TTE-LVH and elevated blood pressure were on antihypertensives.

14 95% CI, 25.4%-32.0%]), those who were taking antihypertensives (24.4% [95% CI, 21.1%-27.8%]), those w

15 , antiulcerants (33%), antiasthmatics (32%), antihypertensives (26%), antidepressants (26%), and anti

16 7% in statins (11.0 to 20.8 million), 76% in antihypertensives (35.3 to 62.2 million), and 37% in P2Y

17 tia (1 trial, low strength of evidence); and antihypertensives (4 trials), NSAIDs (1 trial), and stat

18 ding 3 that studied dementia medications, 16 antihypertensives, 4 diabetes medications, 2 nonsteroida

19 Although 260 patients (69.7%) were taking antihypertensives, 42.9% of all blood pressures recorded

20 1.09] mug/mL; P < .001), fewer patients used antihypertensives (48 patients [36.1%] vs 22 patients [1

21 ise-driven reports, we found that drugs from antihypertensives agents, urologicals, and antithromboti

22 between poststroke cognitive impairment and antihypertensives among hemorrhagic stroke patients.

23 Polypill (antihypertensives and a statin), aspirin, or a combinati

24 Medications, including antihypertensives and antidiabetics, along with dietary

25 ently treated with immunosuppressive agents, antihypertensives and diuretics with partial but limited

26 h hypertension who used up to two classes of antihypertensives and had a systolic blood pressure <180

27 Self-reported use of antihypertensives and statins appears to be relatively a

28 the use of the structure of renin to design antihypertensives and the structure of HIV protease in d

29 to calculate efficacy for any combination of antihypertensives and validated on external trials of du

30 therapeutics, antitumor drugs, antibiotics, antihypertensives, and anti-inflammatories.

31 therapeutics, antitumor drugs, antibiotics, antihypertensives, and anti-inflammatories.

32 therapeutics, antitumor drugs, antibiotics, antihypertensives, and anti-inflammatories.

33 tiviral drugs, antitumor drugs, antibiotics, antihypertensives, and anti-inflammatories.

34 ommonly used drugs, such as anti-infectives, antihypertensives, and cholesterol lowering agents.

35 sterol, and treatment with aspirin, insulin, antihypertensives, and lipid-lowering medications) with

36 t can be mitigated through pretreatment with antihypertensives, and, when appropriate, intensified mo

37 pirical investigations, with 1 study each on antihypertensives, anti-infectives, central nervous syst

38 ls, multiple sclerosis, and prescriptions of antihypertensives, antidepressants, hypnotics, and anxio

39 Preventive treatments include antihypertensives, antiepileptics, antidepressants, calc

40 epressants, anticonvulsants, antihistamines, antihypertensives, antimalarials, relaxants, and broncho

41 efulness of a wide variety of drugs, such as antihypertensives, antipsychotics, and antidepressants.

42 o observed in patients on the combination of antihypertensives, antithrombotic agents, and lipid-lowe

43 Antihypertensives are associated with increased risk of

44 Antihypertensives are effective at reducing the risk of

45 entions (such as cholesterol-lowering drugs, antihypertensives, aspirin, B-vitamins, and antioxidant

46 c regression model that controlled for other antihypertensives, aspirin, steroids, nonsteroidal anti-

47 g loss compared with patients on other or no antihypertensives based on a retrospective analysis of p

48 % CI, 2.19 x 10-4 to 8.95 x 10-4) and use of antihypertensives (beta = 1.19 x 10-2; 95% CI, 6.02 x 10

49 95% CI, 5.19 x 10-4 to 1.15 x 10-3), use of antihypertensives (beta = 3.29 x 10-2; 95% CI, 1.92 x 10

50 by depressed patients declined by 8%; use of antihypertensives by hypertensive patients decreased by

51 We also demonstrate that antihypertensives can be delivered through this device,

52 The Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS) was a UK

53 omised controlled trials of adults receiving antihypertensives compared with placebo or no treatment,

54 Low-dose combination (LDC) antihypertensives consisting of 3 or 4 blood pressure (B

55 in a baseline blood pressure before starting antihypertensives, dermatology-specific PROs serve as a

56 timate [95% CI]: 22.5 [16.5-28.6], P<0.001), antihypertensives (DID estimate [95% CI]: 63.2 [47.3-79.

57 timate [95% CI]: 22.5 [16.5-28.6], P<0.001), antihypertensives (DID estimate [95% CI]: 63.2 [47.3-79.

58 ed to receive a greater number of additional antihypertensives during the remainder of their hospital

59 uconazole), anticonvulsants (eg, valproate), antihypertensives (eg, lisinopril), and immunomodulators

60 We used two of these antihypertensives (felodipine and nilvadipine) for admin

61 lood pressure monitoring after withdrawal of antihypertensives for 3 days was performed 12 months pos

62 hydropyridines (DHP), the most commonly used antihypertensives, function by inhibiting the L-type vol

63 rom the Genetic Epidemiology of Responses to Antihypertensives (GERA) studies.

64 Individuals with hypertension who used antihypertensives had less decline during the 20 years t

65 ressure and dementia, and in turn the use of antihypertensives has been suggested to reduce incidence

66 ic >/= 130 mm Hg, diastolic >/= 85 mm Hg, or antihypertensives); HDL cholesterol < 40 mg/dL (men) or

67 ] = 1.05 to 1.90, P = .022), use of systemic antihypertensives (HR = 2.53, 95% CI = 1.32 to 4.87, P =

68 on management was reflected by the report of antihypertensives in 12% of visits and lipid-lowering me

69 nvincing evidence that any of the individual antihypertensives in clinical use, at the dosages and du

70 d in vivo and found to be good orally active antihypertensives in laboratory animal models.

71 residents who were and were not deprescribed antihypertensives in per-protocol analyses (11.2% vs 8.8

72 ctive studies have suggested the efficacy of antihypertensives in preventing aortic rupture.

73 re are important differences in adherence to antihypertensives in separate classes, with lowest adher

74 similarities, we observed suboptimal use of antihypertensives in this cohort and racial differences

75 sed controlled trial, we compared these oral antihypertensives in two public hospitals in Nagpur, Ind

76 Odds ratios for treatment with oral antihypertensives (including selective beta(1) and nonse

77 1.37 [CI, 1.16 to 1.62]; aPRs for use of >=3 antihypertensives: MACS-2, 1.31 [CI, 1.02 to 1.68], and

78 For those with TTE-LVH, treatment with antihypertensives may reduce the risk of adverse CVD out

79 t AT1R antagonists, frequently prescribed as antihypertensives, may be useful to interrupt this proin

80 models as predictors were: insulin (n = 24), antihypertensives (n = 5), oral antidiabetics (n = 12),

81 to metformin and blood pressure response to antihypertensives (N = 932-28,880).

82 Nonadherence also increased in this group (antihypertensives: odds ratio [OR], 1.60 [95% CI, 1.50 t

83 mpsia or gestational hypertension, requiring antihypertensives on hospital discharge postnatally.

84 alization, defined as receipt of intravenous antihypertensives or oral classes not used prior to admi

85 ified to optimal medical therapy anchored by antihypertensives or thoracic endovascular aortic repair

86 s, aspirin, antidepressants, antiepileptics, antihypertensives, or central nervous system agents (eg,

87 om interventions such as magnesium sulphate, antihypertensives, or transportation to a higher level o

88 nine (P = 0.03), and were less likely to use antihypertensives (P = 0.001).

89 and with -3.9 kg in those who had never used antihypertensives (p=0.026).

90 per 1000 Medicaid beneficiaries of statins, antihypertensives, P2Y12 inhibitors, and direct oral ant

91 , including stimulants, antidepressants, and antihypertensives, plays a fundamental role in the manag

92 All oral antihypertensives reduced blood pressure to the referenc

93 ons from different classes or the use of >=4 antihypertensives regardless of BP levels.

94 use of different prevention treatments: (1) antihypertensives (relative risk, 0.7 [95% confidence in

95 ing of blood pressure with self-titration of antihypertensives (self-management) results in lower blo

96 whether antithrombotic therapy combined with antihypertensives, statins or other agents will further

97 -negative but nonwhite or Hispanic and using antihypertensives, the APO rate was 58.0% and fetal or n

98 ntihypertensive medication timing, switching antihypertensives to bedtime failed to reduce a composit

99 were included if they measured adherence to antihypertensives using medication refill data and conta

100 When number of antihypertensives was added to the models, only higher n

101 Treatment with drugs from five classes of antihypertensives was evaluated in these studies.

102 st risk among patients receiving intravenous antihypertensives (weighted OR, 1.90; 95% CI, 1.65-2.19)

103 gs in the study showed that LDCs with 3 or 4 antihypertensives were an effective and well-tolerated B

104 Antihypertensives were associated with an increased risk

105 Antihypertensives were associated with an increased risk

106 For nonlive deliveries, most antihypertensives were replaced by vitamin A derivatives

107 nd smoking, presence of diabetes, and use of antihypertensives were stronger than the standard surviv

108 Group 1 patients who were on antihypertensives were washed out for a 4-week period, p

109 [1.4] years) comparing 2 commonly prescribed antihypertensives, which used an EHR-based recruitment m

110 f had chronic hypertension, and most were on antihypertensives with normal blood pressure.